These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7079936)

  • 1. Medical management of patients following a ruptured cerebral aneurysm, with epsilon-aminocaproic acid, kanamycin, and reserpine.
    Knuckey NW; Stokes BA
    Surg Neurol; 1982 Mar; 17(3):181-5. PubMed ID: 7079936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced incidence of cerebral ischemia following rupture of intracranial aneurysms.
    Zervas NT; Candia M; Candia G; Kido D; Pessin MS; Rosoff CB; Bacon V
    Surg Neurol; 1979 May; 11(5):339-44. PubMed ID: 375449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
    Nibbelink DW; Torner JC; Henderson WG
    Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus.
    Kenning JA; Heros RC; Dujovny M; Latchaw RE; Nelson D
    Surg Neurol; 1984 Feb; 21(2):159-64. PubMed ID: 6701753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.
    Ameen AA; Illingworth R
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):220-6. PubMed ID: 7229645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
    Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
    Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid.
    Sonntag VK; Stein BM
    J Neurosurg; 1974 Apr; 40(4):480-5. PubMed ID: 4814379
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid.
    Chowdhary UM; Carey PC; Hussein MM
    Lancet; 1979 Apr; 1(8119):741-3. PubMed ID: 85988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms.
    Girvin JP
    Trans Am Neurol Assoc; 1973; 98():150-2. PubMed ID: 4784923
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
    Nibbelink DW
    Stroke; 1971; 2(6):555-8. PubMed ID: 5164583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antifibrinolytic treatment after subarachnoid hemorrhage].
    Marchel A
    Neurol Neurochir Pol; 1992; 26(4):502-10. PubMed ID: 1484577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
    Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
    Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and postoperative management of cerebral aneurysms.
    Peerless SJ
    Clin Neurosurg; 1979; 26():209-31. PubMed ID: 544124
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211.
    Shaw MD; Miller JD
    Lancet; 1974 Oct; 2(7884):847-8. PubMed ID: 4138300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Subarachnoid hemorrhage caused by a ruptured aneurysm and secondary cerebral vasospasm].
    Gómez López PA; López Ferro MO
    Rev Clin Esp; 1983 Nov; 171(4):231-5. PubMed ID: 6364268
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
    Spallone A
    Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative management of patients with ruptured intracranial aneurysms.
    Ransohoff J; Goodgold A; Benjamin MV
    J Neurosurg; 1972 May; 36(5):525-30. PubMed ID: 5026538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.